Bogol, Maria Paz S.
HRN: 01-35-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/26/2024
LEVOFLOXACIN 500MG (TAB)
03/26/2024
04/02/2024
PO
500mg
OD
Pleural Effusion Sec To CAP-HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes